Modern Fertility is a women’s health company that empowers all women to make informed decisions about their health, starting with fertility. Modern Fertility takes the same lab tests previously confined to infertility clinics and makes them more accessible by enabling women to administer a finger-prick at home or going to a nearby lab for a traditional blood draw for a fraction of the cost. By educating women and arming them with powerful information about their reproductive health, the company is closing the fertility information gap and enabling women to have more data for decision-making. Co-founded by Afton Vechery and Carly Leahy, Modern Fertility has raised a total of $7 million to advance fertility science so women can learn more about their bodies on their own terms.

Modern Fertility is a women’s health company that empowers all women to make informed decisions about their health, starting with fertility. Modern Fertility takes the same lab tests previously confined to infertility clinics and makes them more accessible by enabling women to administer a finger-prick at home or going to a nearby lab for a traditional blood draw for a fraction of the cost. By educating women and arming them with powerful information about their reproductive health, the company is closing the fertility information gap and enabling women to have more data for decision-making. Co-founded by Afton Vechery and Carly Leahy, Modern Fertility has raised a total of $7 million to advance fertility science so women can learn more about their bodies on their own terms.

Prelude is a comprehensive fertility company focused on providing proactive fertility care to improve people’s chances of having healthy babies when they’re ready. Founded in 2016 by serial entrepreneur Martín Varsavsky, Lee Equity Partners, Reproductive Biology Associates and My Egg Bank North America, the company was established to give men and women more reproductive choices and control over their biological clocks using The Prelude Method. The Prelude Method is a four-step process that includes egg and sperm freezing, genetic testing, embryo creation, and single embryo transfer. By coupling earlier decision making with the latest reproductive science and technology, The Prelude Method can dramatically increase the probability of having a healthy baby and decrease the chances of requiring infertility therapy later in life.

Prelude is a comprehensive fertility company focused on providing proactive fertility care to improve people’s chances of having healthy babies when they’re ready. Founded in 2016 by serial entrepreneur Martín Varsavsky, Lee Equity Partners, Reproductive Biology Associates and My Egg Bank North America, the company was established to give men and women more reproductive choices and control over their biological clocks using The Prelude Method. The Prelude Method is a four-step process that includes egg and sperm freezing, genetic testing, embryo creation, and single embryo transfer. By coupling earlier decision making with the latest reproductive science and technology, The Prelude Method can dramatically increase the probability of having a healthy baby and decrease the chances of requiring infertility therapy later in life.